The article, published in Frontiers in Nuclear Medicine by Chuangyan Zhai of the Third Affiliated Hospital of Southern Medical University in Guangzhou and the Shanghai Key Laboratory of Molecular Imaging, proposes a conceptual administrative blueprint called the Management-Driven Integration Loop. Its central claim is provocative for a field dominated by physicists and physicians: the biggest barrier to molecular imaging is not technical but managerial. Molecular imaging often represents the largest capital expenditure in an institution, yet its findings are frequently treated as supplementary data rather than central drivers of treatment planning. Opportunities to guide personalized therapy, avoid unnecessary procedures, and optimize resource use are systematically overlooked.

Zhai is careful to note that this isolation rarely reflects the skills or dedication of nuclear medicine specialists. Instead, it reflects functional silos, inconsistent interdepartmental communication, and incentive structures that fail to reward collaborative clinical impact. Since informal collaboration alone has proven insufficient, the framework assigns administrators the crucial role of dismantling these systemic barriers through clear policies, workflow integration, and performance accountability. Drawing a parallel to pathology, which long fought for recognition as the definitive diagnostic foundation of medicine, the article argues that nuclear medicine must similarly be repositioned as a navigational hub for precision medicine at the molecular level.

The first pillar of the framework, strategic resource allocation, tackles the physical roots of isolation. Nuclear medicine departments are often marginalized by strict radiation shielding requirements, frequently relegated to basements or remote corridors where spontaneous consultation with clinicians becomes nearly impossible. To counter this, the article proposes satellite workstations embedded within core clinical hubs such as oncology wards, cardiology centers, and neurology units. These nodes would function as interdisciplinary spaces where nuclear medicine specialists participate directly in clinical rounds, moving the field toward an imaging-to-bedside model that reduces consultation delays and ensures molecular insights inform treatment at an earlier stage.

Physical proximity alone, however, may not bridge interdisciplinary gaps. The framework therefore introduces a formal Clinical-NM Liaison role, distinct from nuclear medicine physicians focused on volume-based reporting. The liaison would serve as a central clinical coordinator, analogous to specialized coordinators in oncology multidisciplinary teams, synthesizing molecular data with genomic and pathological findings to provide a cohesive biological map for the treating physician. The liaison would proactively review complex cases and suggest adjustments to scanning parameters, such as tracer selection, imaging timing, or delayed scans, so that results are directly actionable for surgeons or oncologists. Candidates could be drawn from senior physicians undergoing targeted cross-training, supported by dedicated time allocations and direct integration with hospital information and imaging systems to mitigate burnout.

Technological support completes the resource allocation pillar. Cloud-based Internet of Things monitoring platforms could provide real-time visibility into scanner usage, patient flow, and appointment backlogs across multiple hospital sites. Administrators could then implement dynamic resource leveling that prioritizes cases by clinical value rather than chronological booking. When a primary cancer center’s scanner is overbooked, routine follow-up scans could be redirected to underutilized satellite scanners, while urgent, high-complexity cases are scheduled on the most advanced, high-resolution equipment. This approach is designed to improve patient access, reduce waiting times, prevent equipment idling, and deliver a measurable operational return on investment.

The second pillar, process re-engineering, institutionalizes interdisciplinary collaboration through protocol-based clinical pathways embedded in electronic health records. These pathways would identify key clinical inflection points, such as initial staging for high-risk prostate cancer or therapy response assessment in lymphoma, where PET/CT evaluations using PSMA or FDG tracers are mandated by hospital-wide standard operating procedures. Structured multidisciplinary team integration would then ensure nuclear medicine physicians provide integrative insights that synthesize imaging with therapeutic possibilities rather than merely reporting findings. An MDT feedback and decision-tracking loop, integrated into the hospital information system, would systematically capture measurable outcomes such as diagnostic upstaging, downstaging, or fundamental shifts in treatment plans, alongside operational metrics like average length of stay and total cost of care. Data on clinical return on investment would feed back into the resource allocation phase, allowing administrators to redeploy satellite workstations or liaison personnel to the highest-impact clinical areas and thereby complete the integration loop.

The third pillar, performance leverage, confronts a structural misalignment at the heart of hospital economics. Traditional fee-for-service compensation deters interdisciplinary collaboration because time spent in multidisciplinary meetings yields no direct financial return for the nuclear medicine department. The framework proposes a multidimensional Total Performance Index in which quantitative output such as scan counts or relative value units is weighted alongside Decision Contribution, capturing validated impacts on clinical staging or treatment plan changes, and Synergy and Research, capturing joint publications and clinical grants. Administrators could strategically adjust the weighting coefficients during the integration phase, for example allocating 0.4 to quantity, 0.4 to decision, and 0.2 to synergy, signaling that active clinical consultation and collaborative innovation matter as much as technical imaging volume. Decision contributions would be documented within the hospital information system and verified by an interdisciplinary audit committee to safeguard objectivity. Administratively protected seed grants, accessible only through joint applications from nuclear medicine and at least one other clinical department, would further break budget silos and foster a culture of mutual dependency.

The fourth pillar, brand building, envisions repositioning the department as a multidisciplinary Precision Diagnosis and Therapy Center, formally recognizing nuclear medicine as the hospital’s navigational hub for oncology, cardiology, and neurology. Leveraging IoT and cloud-based platforms, administrators could explore a one-stop diagnostic-to-treatment workflow in which patients move from PET/CT scanning to multidisciplinary consultation within a single day. A key proposed metric is Time-to-Decision, measuring the interval from initial clinical suspicion to an MDT-approved treatment plan. Benchmarking against international standards from the Society of Nuclear Medicine and Molecular Imaging and the European Association of Nuclear Medicine, participation in multicenter trials, and hosting regional management forums could generate an academic halo effect that elevates the reputation of the hospital and its associated departments.

The article acknowledges substantial implementation challenges. Large tertiary centers are best positioned to pilot the full suite of recommendations, while smaller hospitals may need phased adoption prioritizing virtual MDT participation and basic protocol alignment over structural overhauls. Value-based incentives may encounter regulatory hurdles in regions where reimbursement remains strictly tied to fee-for-service models, the liaison role may face certification and billing challenges, and technical fragmentation among hospital information systems from different vendors often blocks interoperability. Perhaps the most significant barrier is the deeply ingrained siloed culture of medical specialties, which requires top-tier leadership commitment to overcome. While the framework remains conceptual rather than derived from prospective pilot data, its illustrative example in high-risk prostate cancer management, where coordinated PSMA PET/CT evaluation before MDT discussion could reduce unnecessary procedures and shorten time-to-decision, offers a practical vision of how administrative coordination, specialized personnel, and molecular imaging could function synergistically. The article closes with a call to action for hospital leadership to drive institutional excellence and improve patient outcomes through proactive, systematic governance.

Subject of Research: Health

Article Title: Driving clinical excellence through a management driven framework for integrating nuclear medicine into hospital ecosystems

Article References: Zhai, C. (2026). Driving clinical excellence through a management driven framework for integrating nuclear medicine into hospital ecosystems. Frontiers in Nuclear Medicine, 6, Article 1837305. https://doi.org/10.3389/fnume.2026.1837305

Image Credits: AI Generated

DOI: 10.3389/fnume.2026.1837305

Keywords: nuclear medicine, hospital management, molecular imaging, PET/CT, interdisciplinary collaboration, health policy, Driving, clinical, excellence, management, driven, framework